Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1995-02-22
1997-04-08
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
540 95, A61K 3158, C07J 4300
Patent
active
056188072
ABSTRACT:
Compounds of the general formula (1) ##STR1## wherein X represents the residue of the A, B and C rings of a asteroid, R represents a hydrogen atom or an alkyl group of 1 to 4 carbon atoms, R.sup.14 represents a hydrogen atom and R.sup.15 represents a hydrogen atom or an alkyl or alkoxy group of 1-4 carbon atoms, or a hydroxy or alkylcarbonyloxy group of 2 to 5 carbon atoms or R.sup.14 and R.sup.15 together represent a double bond, and R.sup.16 represents a hydrogen atom or an alkyl group of 1 to 4 carbon atoms, in the form of the free bases or pharmaceutically acceptable acid addition salts, are used for treatment of androgen-dependent disorders, especially prostatic cancer, and also oestrogen-dependent disorders such as breast cancer.
REFERENCES:
Wicha et al, Bulletin of the Polish Acad of Sciences, chemistry 32 pp. 75-83 (1984).
Wicha et al Heterocycles vol. 16 pp. 521-524 (1981).
Wicha et al, Heterocycles vol. 20 pp. 231-234 (1983).
J. Wicha et al. "Cardiotonic steroids. Part 8. Synthesis of 17.beta . . . " Bulletin of the Polish Acad. of Sciences, Chemistry vol. 33 No. 1-2, 1985, pp. 19-27.
J. Wicha et al. "Cardiotonic steriods. Part 7. Synthesis of 17.beta . . . " Bulletin of the Polish Acad. of Sciences. Chemistry, vol. 32 No. 1-2, 1984, pp. 75-83.
J. Wicha et al. "Synthesis of 17.beta-pyridyl . . . " Heterocycles, vol. 16 No. 4, 1981, pp. 521-524.
J. Wicha et al. "Synthesis and Molecular biological activity of the pyridine . . . " Heterocycles. vol. 20 No. 2, 1983, pp. 231-234.
G. A., Potter et al. "Discovery of Highly potent and selective enzyme . . . " Poster presented at the SmithKline Beecham Research Symp., Robinson College, Cambridge, England, 25-26 Mar. 1993.
S. E. Barrie et al. "Highly potent inhibitors of human cytochrome . . . " Poster presented at the British Association for Cancer Research meeting in Sheffield, England, 28-31 Mar. 1993.
G. A. Potter et al. "Highly potent inhibitors of human cytrochrome P-450 . . . " Poster presented at the third Drug Discovery & Development Symp., San Diego, CA, USA, 22-24 Jul. 1993.
B. Schweder et al. "Synthesis des . . . " J. Prakt. Chem. 335, 201-204 (1993).
D. H. R. Barton et al. "An improved preparation of vinyl iodides . . . " Tetrahedron letters, 24, 1605-1608 (1983).
D. H. R. Barton et al. "Studies on the oxidation of hydrazones with iodide . . . ", Tetrahedron 44, 147-162 (1988).
M. J. Shiao. "New synthesis of azabufalin from C-17 steroidal ketones", J. Org. Chem. 47, 5189-5191 (1982).
Barrie Susan E.
Hardcastle Ian R.
Jarman Michael
Potter Gerard A.
Bottino Anthony
British Technology Group Limited
Shah Mukund J.
LandOfFree
Method for preparing 17-substituted steroids useful in cancer tr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preparing 17-substituted steroids useful in cancer tr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preparing 17-substituted steroids useful in cancer tr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2397824